Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: A potential role for dysregulation of the transforming growth factor-β pathway

European Journal of Cancer

Volumn 43, Issue 3, 2007, Pages 624-631

  Baker, Kristi ^a   Zlobec, Inti ^a   Tornillo, Luigi ^b   Terracciano, Luigi ^b   Jass, Jeremy R ^a   Lugli, Alessandro ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Colorectal cancer; Intraepithelial lymphocytes; Mismatch repair; Transforming growth factor ; Tumour infiltrating lymphocytes

Indexed keywords

KI 67 ANTIGEN; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; COLORECTAL CANCER; DISEASE MARKER; DNA MICROARRAY; EPITHELIUM CELL; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846577890     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.11.012     Document Type: Article

References (30)

1. Jass J.R., Whitehall V.L., Young J., and Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology 123 3 (2002) 862-876
2. Guidoboni M., Gafa R., Viel A., et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159 1 (2001) 297-304
3. Quinn E., Hawkins N., Yip Y.L., Suter C., and Ward R. CD103+ intraepithelial lymphocytes - a unique population in microsatellite unstable sporadic colorectal cancer. Eur J Cancer 39 4 (2003) 469-475
4. Di Sabatino A., Ciccocioppo R., D'Alo S., et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 49 3 (2001) 380-386
5. Ebert E.C., and Roberts A.I. Lymphokine-activated killing by human intestinal lymphocytes. Cell Immunol 146 1 (1993) 107-116
6. Takemoto N., Konishi F., Yamashita K., et al. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration. Jpn J Clin Oncol 34 2 (2004) 90-98
7. Dolcetti R., Viel A., Doglioni C., et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154 6 (1999) 1805-1813
8. Ishikawa T., Fujita T., Suzuki Y., et al. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res 63 17 (2003) 5564-5572
9. Banerjea A., Bustin S.A., and Dorudi S. The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol 3 (2005) 26
10. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 5215 (1995) 1336-1338
11. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 6958 (2003) 577-584
12. Mulder K.M. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11 1-2 (2000) 23-35
13. Baker K., Chong G., Foulkes W.D., and Jass J.R. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes. Histopathology 49 4 (2006) 371-380
14. Sauter G., Simon R., and Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2 12 (2003) 962-972
15. Lugli A., Zlobec I., Gunthert U., et al. Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer. Mod Pathol 19 10 (2006) 1302-1309
16. Lugli A., Zlobec I., Minoo P., et al. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer - a tissue microarray-based approach. Hum Pathol 37 8 (2006) 1022-1031
17. Hampel H., Stephens J.A. Pukkala E., et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129 2 (2005) 415-421
18. Hanley J.A. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29 3 (1989) 307-335
19. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1998), CRC Press
20. Pages F., Berger A., Camus M., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. New Engl J Med 353 25 (2005) 2654-2666
21. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 5795 (2006) 1960-1964
22. Dunn G.P., Old L.J., and Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21 2 (2004) 137-148
23. Afrakhte M., Moren A., Jossan S., et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun 249 2 (1998) 505-511
24. Godar S., Horejsi V., Weidle U.H., et al. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol 29 3 (1999) 1004-1013
25. Robinson P.W., Green S.J., Carter C., Coadwell J., and Kilshaw P.J. Studies on transcriptional regulation of the mucosal T-cell integrin alphaEbeta7 (CD103). Immunology 103 2 (2001) 146-154
26. Karecla P.I., Green S.J., Bowden S.J., Coadwell J., and Kilshaw P.J. Identification of a binding site for integrin alphaEbeta7 in the N-terminal domain of E-cadherin. J Biol Chem 271 48 (1996) 30909-30915
27. Barnard J.A., Beauchamp R.D., Coffey R.J., and Moses H.L. Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci USA 86 5 (1989) 1578-1582
28. Wan M., Tang Y., Tytler E.M., et al. Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1. J Biol Chem 279 15 (2004) 14484-14487
29. Bhowmick N.A., Zent R., Ghiassi M., McDonnell M., and Moses H.L. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 276 50 (2001) 46707-46713
30. Derynck R., Akhurst R.J., and Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29 2 (2001) 117-129